MedPath

Evaluation of COVA™+ CARD in Adult Cardiac Surgery

Withdrawn
Conditions
Safety
Tolerance
Registration Number
NCT03140098
Lead Sponsor
Biom'Up France SAS
Brief Summary

The aim of this observational study is to evaluate the safety of the guided healing and adhesion prevention membrane, COVA™+ CARD, in adult cardiac surgery. The causality of the collagen membrane according to the occurrence of peri and post-operative complications will be evaluated.

Detailed Description

Assessment of the safety of COVA™+ CARD, collagen membrane to prevent adhesion appearance, in cardiac surgery in adult patients:

* collection of post-operative complications, causality of the membrane

* collection of complications in the 3-month period after the surgery, causality of the membrane

* collection of peri-operative complications, causality of the membrane

* collection of complications, 3 months after the surgery

* assessment of the efficacy of COVA™+ CARD if re-operation

* assessment of the surgeon's satisfaction

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • 18 years of age or older
  • Cardiac surgery using COVA™+ CARD
Exclusion Criteria
  • In accordance with the instruction for use (IFU) of the medical device.
  • Refusal of participation to the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the tolerance of COVA™+ CARD in cardiac surgery3 months

Recording of complications reported in the 3-month postoperative period and determination of the causality of the collagen membrane.

Secondary Outcome Measures
NameTimeMethod
Evaluation of the tolerance of COVA™+ CARD in cardiac surgeryHospitalization stay (up to 30 days)

Recording of the immediate postoperative complications and determination of the causality of the collagen membrane.

© Copyright 2025. All Rights Reserved by MedPath